Copyright
©The Author(s) 2016.
World J Hepatol. Jan 18, 2016; 8(2): 92-106
Published online Jan 18, 2016. doi: 10.4254/wjh.v8.i2.92
Published online Jan 18, 2016. doi: 10.4254/wjh.v8.i2.92
Figure 2 Direct acting antiviral agents.
Modified from Alexopoulou et al[121]. Interferon-based combination treatment for chronic hepatitis C in the era of direct acting antivirals. Annals of Gastroenterology 2015; 28: 55-65. NPIs: Nucleoside polymerase inhibitors; NNPIs: Non-nucleoside polymerase inhibitors; DAA: Direct acting antiviral.
- Citation: Bertino G, Ardiri A, Proiti M, Rigano G, Frazzetto E, Demma S, Ruggeri MI, Scuderi L, Malaguarnera G, Bertino N, Rapisarda V, Di Carlo I, Toro A, Salomone F, Malaguarnera M, Bertino E, Malaguarnera M. Chronic hepatitis C: This and the new era of treatment. World J Hepatol 2016; 8(2): 92-106
- URL: https://www.wjgnet.com/1948-5182/full/v8/i2/92.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i2.92